DIAGNOS Inc., a Montreal-based medical AI company, presents its FLAIRE AI platform at the AI & Technology Hybrid Virtual Investor Conference on April 11th.
Montreal-based AI company, DIAGNOS Inc., specializing in medical AI, will present at the AI & Technology Hybrid Virtual Investor Conference on April 11th. CEO Andre Larente will discuss the company's FLAIRE AI platform, which powers applications like CARA (Computer Assisted Retina Analysis) for large-scale patient screening. Their FDA, Health Canada, and Saudi FDA-cleared PACS solutions are set for release in the optometry market, with EssilorLuxottica as their largest global partner.
April 09, 2024
3 Articles